Actively Recruiting
Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event
Led by Coordinación de Investigación en Salud, Mexico · Updated on 2024-08-23
119
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this clinical trial is to measure the effect of Rehabilitation with Virtual Reality or Modified Constraint-Induced Movement Therapy on hemiparesis in patients with Cerebral Vascular Event. The question to be answered is: What is the effect of different therapeutic modalities supported by Virtual Reality or Modified Constraint-Induced Movement Therapy compared with usual Physical and Occupational Therapy on motor recovery of paretic limbs in patients with Cerebrovascular Event? The patients will carry out activities of: * Virtual reality or * Movement Restriction-Induction Therapy. The investigators will compare the changes in the functionality of the paretic hemibody with a group undergoing regular physical and occupational therapy, as well as language and treatment-related satisfaction.
CONDITIONS
Official Title
Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients between 35 and 70 years of age with a clinical and tomographic diagnosis of cerebrovascular event in the middle cerebral artery territory
- Patients with hemiparesis caused by the cerebrovascular event
- Patients with Ashworth scale score up to 2 and Brunnstrom scale score at least 4
- Patients with or without aphasia
- Patients 1 to 3 months from hospital discharge after the cerebrovascular event
- Patients of any sex with cerebrovascular event
- Patients without cognitive deficits related to the vascular event
- Patients or their family members willing to sign informed consent
You will not qualify if you...
- Patients who develop dementia or neurological-psychomotor complications during the study
- Patients who experience a new cerebrovascular event during the study
- Patients who do not complete at least 90% of the therapy program
- Patients lacking family support or with secondary gain detected
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Mexicano del Seguro Social
Mexico City, Mexico, 06720
Actively Recruiting
Research Team
J
Juan Garduño-Espinosa, Doctorado
CONTACT
M
María del Carmen Rojas-Sosa, Doctorado
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here